# Biomarker for Infection Risk in CLL and MM

> **NCT05844033** · — · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Multiple Myeloma
- Chronic Lymphocytic Leukemia

## Interventions

- **OTHER:** Screening

## Key facts

- **NCT ID:** NCT05844033
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05844033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05844033, "Biomarker for Infection Risk in CLL and MM". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05844033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*